The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The goal of this research is to see if pancreatic polypeptide (PP), a hormone that is
naturally produced by the pancreas and that works to control the amount of glucose that the
liver makes, will reduce the amount of insulin required for people who must take insulin to
maintain their normal blood glucose level.